These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 18165619
1. Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy. O'Neil BH, Venook AP. Oncologist; 2007 Dec; 12(12):1425-32. PubMed ID: 18165619 [Abstract] [Full Text] [Related]
2. Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy. Lencioni R. Crit Rev Oncol Hematol; 2012 Aug; 83(2):216-24. PubMed ID: 22142656 [Abstract] [Full Text] [Related]
4. Closing remarks. Kudo M. Clin Drug Investig; 2012 Aug 08; 32 Suppl 2():52. PubMed ID: 22873627 [No Abstract] [Full Text] [Related]
5. Sorafenib in hepatocellular carcinoma. Josephs DH, Ross PJ. Br J Hosp Med (Lond); 2010 Aug 08; 71(8):451-6. PubMed ID: 20852487 [Abstract] [Full Text] [Related]
6. Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan. Kudo M, Ueshima K. Oncology; 2010 Jul 08; 78 Suppl 1():154-66. PubMed ID: 20616599 [Abstract] [Full Text] [Related]
7. Novel molecular therapies in hepatocellular carcinoma. Faivre S, Bouattour M, Raymond E. Liver Int; 2011 Jan 08; 31 Suppl 1():151-60. PubMed ID: 21205154 [Abstract] [Full Text] [Related]
8. Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials. Zhang T, Ding X, Wei D, Cheng P, Su X, Liu H, Wang D, Gao H. Anticancer Drugs; 2010 Mar 08; 21(3):326-32. PubMed ID: 20016366 [Abstract] [Full Text] [Related]
9. Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case report. Inuzuka T, Nishikawa H, Sekikawa A, Takeda H, Henmi S, Sakamoto A, Saito S, Kita R, Kimura T, Osaki Y, Kudo M. Oncology; 2011 Mar 08; 81 Suppl 1():152-7. PubMed ID: 22212950 [Abstract] [Full Text] [Related]
10. Markedly effective local control of hepatocellular carcinoma with a poor prognosis by combined multimodal therapy with sorafenib as a neoadjuvant approach. Bathaix F, Marion D, Cuinet M, Maillard E, Zoulim F, Mornex F, Merle P. Gastroenterol Clin Biol; 2010 Mar 08; 34(4-5):314-8. PubMed ID: 20207091 [Abstract] [Full Text] [Related]
11. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis. Wörns MA, Weinmann A, Pfingst K, Schulte-Sasse C, Messow CM, Schulze-Bergkamen H, Teufel A, Schuchmann M, Kanzler S, Düber C, Otto G, Galle PR. J Clin Gastroenterol; 2009 Mar 08; 43(5):489-95. PubMed ID: 19247201 [Abstract] [Full Text] [Related]
12. Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma. Park JW, Koh YH, Kim HB, Kim HY, An S, Choi JI, Woo SM, Nam BH. J Hepatol; 2012 Jun 08; 56(6):1336-42. PubMed ID: 22314421 [Abstract] [Full Text] [Related]
13. [Use of sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations]. Boige V, Barbare JC, Rosmorduc O, Groupe de travail carcinome hépatocellulaire Prodige-Afef. Gastroenterol Clin Biol; 2008 Jan 08; 32(1 Pt. 1):3-7. PubMed ID: 18341970 [No Abstract] [Full Text] [Related]
18. Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenib. Cabibbo G, Rolle E, De Giorgio M, Genco C, Pressiani T, Spada F, Sacco R, HCC Working Group. Expert Rev Anticancer Ther; 2011 Dec 08; 11(12):1807-16. PubMed ID: 22049974 [Abstract] [Full Text] [Related]
19. Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy. Saab S, McTigue M, Finn RS, Busuttil RW. Exp Clin Transplant; 2010 Dec 08; 8(4):307-13. PubMed ID: 21143097 [Abstract] [Full Text] [Related]
20. [Treatment of advanced hepatocellular carcinoma]. Forner A, Rodríguez De Lope C, Reig M, Bruix J. Gastroenterol Hepatol; 2010 Dec 08; 33(6):461-8. PubMed ID: 20227796 [Abstract] [Full Text] [Related] Page: [Next] [New Search]